1-8 of 8
Keith C. Bible
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1278: Phase 1 study of CS-7017, an oral PPAR-γ agonist, in combination with paclitaxel in advanced anaplastic thyroid cancer

Robert C. Smallridge, John A. Copland, Marcia S. Brose, J. Trad Wadsworth, Yariv Houvras, Keith C. Bible, Manisha H. Shah, Ann W. Gramza, Joshua P. Klopper, Reinhard von Roemeling
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1278.
https://doi.org/10.1158/1538-7445.AM2011-1278
Published: 15 April 2011
View article titled, Abstract 1278: Phase 1 study of CS-7017, an oral PPAR-γ agonist, in combination with paclitaxel in advanced anaplastic thyroid cancer
Journal Articles

Abstract 3597: Pazopanib potentiates paclitaxel-induced mitotic catastrophe in association with inhibition of aurora kinases

Crescent R. Isham, Vivian Negron, Wilma L. Lingle, Kelly E. Fisher, Rakesh Kumar, Mayo Clinic Endocrine Malignancies Disease Oriented Group, Keith C. Bible
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3597.
https://doi.org/10.1158/1538-7445.AM2011-3597
Published: 15 April 2011
View article titled, Abstract 3597: Pazopanib potentiates paclitaxel-induced mitotic catastrophe in association with inhibition of aurora kinases
Journal Articles

Abstract 4480: Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone

Michael E. Menefee, Keith C. Bible, Christina Von Roemeling, John Al Copland
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4480.
https://doi.org/10.1158/1538-7445.AM10-4480
Published: 15 April 2010
View article titled, Abstract 4480: Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone
Journal Articles

Loss of Expression of a New Member of the DNAJ Protein Family Confers Resistance to Chemotherapeutic Agents Used in the Treatment of Ovarian Cancer

Viji Shridhar, Keith C. Bible, Julie Staub, Rajeswari Avula, Yean Kit Lee, Kimberly Kalli, Haojie Huang, Lynn C. Hartmann, Scott H. Kaufmann, David I. Smith
Journal: Cancer Research
Cancer Res (2001) 61 (10): 4258–4265.
Published: 01 May 2001
View article titled, Loss of Expression of a New Member of the DNAJ Protein Family Confers Resistance to Chemotherapeutic Agents Used in the Treatment of Ovarian Cancer
Open the PDF for Loss of Expression of a New Member of the DNAJ Protein Family Confers Resistance to Chemotherapeutic Agents Used in the Treatment of Ovarian Cancer in another window
Journal Articles

The HER Tyrosine Kinase Inhibitor CI1033 Enhances Cytotoxicity of 7-Ethyl-10-hydroxycamptothecin and Topotecan by Inhibiting Breast Cancer Resistance Protein-mediated Drug Efflux

Charles Erlichman, Scott A. Boerner, Christopher G. Hallgren, Rebecca Spieker, Xiao-Yang Wang, C. David James, George L. Scheffer, Marc Maliepaard, Douglas D. Ross, Keith C. Bible, Scott H. Kaufmann
Journal: Cancer Research
Cancer Res (2001) 61 (2): 739–748.
Published: 01 January 2001
View article titled, The HER Tyrosine Kinase Inhibitor CI1033 Enhances Cytotoxicity of 7-Ethyl-10-hydroxycamptothecin and Topotecan by Inhibiting Breast Cancer Resistance Protein-mediated Drug Efflux
Open the PDF for The HER Tyrosine Kinase Inhibitor CI1033 Enhances Cytotoxicity of 7-Ethyl-10-hydroxycamptothecin and Topotecan by Inhibiting Breast Cancer Resistance Protein-mediated Drug Efflux in another window
Journal Articles

Flavopiridol Binds to Duplex DNA

Keith C. Bible, Roy H. Bible, Jr., Timothy J. Kottke, Phyllis A. Svingen, Kun Xu, Yuan-Ping Pang, Elisabeth Hajdu, Scott H. Kaufmann
Journal: Cancer Research
Cancer Res (2000) 60 (9): 2419–2428.
Published: 01 May 2000
View article titled, Flavopiridol Binds to Duplex DNA
Open the PDF for Flavopiridol Binds to Duplex DNA in another window
Journal Articles

Cytotoxic Synergy between Flavopiridol (NSC 649890, L86-8275) and Various Antineoplastic Agents: The Importance of Sequence of Administration

Keith C. Bible, Scott H. Kaufmann
Journal: Cancer Research
Cancer Res (1997) 57 (16): 3375–3380.
Published: 01 August 1997
View article titled, Cytotoxic Synergy between Flavopiridol (NSC 649890, L86-8275) and Various Antineoplastic Agents: The Importance of Sequence of Administration
Open the PDF for Cytotoxic Synergy between Flavopiridol (NSC 649890, L86-8275) and Various Antineoplastic Agents: The Importance of Sequence of Administration in another window
Journal Articles

Flavopiridol: A Cytotoxic Flavone That Induces Cell Death in Noncycling A549 Human Lung Carcinoma Cells

Keith C. Bible, Scott H. Kaufmann
Journal: Cancer Research
Cancer Res (1996) 56 (21): 4856–4861.
Published: 01 November 1996
View article titled, Flavopiridol: A Cytotoxic Flavone That Induces Cell Death in Noncycling A549 Human Lung Carcinoma Cells
Open the PDF for Flavopiridol: A Cytotoxic Flavone That Induces Cell Death in Noncycling A549 Human Lung Carcinoma Cells in another window